FL
JAZZ icon

Fort LP’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fort LP’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,682
Closed -$418K – 269
2022
Q1 		$418K Sell
2,682
-1,935
-42% -$281K 0.16% 224
2021
Q4 		$588K Sell
4,617
-3,100
-40% -$407K 0.19% 209
2021
Q3 		$1M Sell
7,717
-2,653
-26% -$401K 0.33% 150
2021
Q2 		$1.84M Sell
10,370
-1,069
-9% -$185K 0.53% 46
2021
Q1 		$1.88M Sell
11,439
-37
-0.3% -$6.09K 0.53% 54
2020
Q4 		$1.89M Buy
11,476
+3,095
+37% +$461K 0.57% 12
2020
Q3 		$1.2M Buy
8,381
+4,185
+100% +$519K 0.5% 72
2020
Q2 		$463K Sell
4,196
-3,980
-49% -$440K 0.25% 182
2020
Q1 		$815K Buy
8,176
+1,660
+25% +$215K 0.18% 205
2019
Q4 		$973K Sell
6,516
-3,025
-32% -$412K 0.17% 207
2019
Q3 		$1.22M Sell
9,541
-2,833
-23% -$380K 0.23% 189
2019
Q2 		$1.76M Buy
12,374
+1,414
+13% +$190K 0.34% 159
2019
Q1 		$1.57M Buy
10,960
+2,987
+37% +$390K 0.32% 166
2018
Q4 		$988K Buy
7,973
+5,018
+170% +$744K 0.23% 180
2018
Q3 		$497K Buy
+2,955
New +$508K 0.11% 216

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Fort LP's JAZZ Position: Q2 2022 in Review

Fort LP sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2022, closing a stake of 2,682 shares — an estimated $418K sold.

Fort LP first reported a position in JAZZ in Q3 2018 and held it in 15 quarters. The position peaked at $1.89M in Q4 2020. 468 funds tracked by Wall St. Rank hold JAZZ as of Q2 2022.

  • Fort LP reported no remaining Jazz Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Fort LP sold 2,682 Jazz Pharmaceuticals shares in Q2 2022, an estimated $418K.
  • Fort LP first reported a position in Jazz Pharmaceuticals in Q3 2018 and held it in 15 quarters.
  • Fort LP's Jazz Pharmaceuticals position peaked at $1.89M in Q4 2020.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2022.

Based on Fort LP's 13F filing for Q2 2022, filed 12 Aug 2022.